Product image of Nicorette Bucomist (Nicotine) supplied by GNH India

Nicorette Bucomist

Active Ingredient:
Nicotine
Origin:
EU

Nicorette Bucomist (Nicotine)

Nicotine, the active ingredient in Nicorette Bucomist, is a nicotine replacement therapy presented as an oromucosal product for buccal use. The formulation is designed for convenient placement in the mouth, allowing nicotine absorption through the oral mucosa. It is intended to aid adult smokers who wish to quit by delivering controlled nicotine to lessen withdrawal symptoms and cravings.

GNH India supplies Nicorette Bucomist as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Manufacturer / TM Owner

Jntl Consumer Health (Portugal) Lda.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nicorette Bucomist is a nicotine replacement therapy that addresses tobacco dependence and supports smoking cessation.

  • Smoking cessation: helps adult smokers quit by reducing cravings and withdrawal symptoms.
  • Tobacco dependence: provides a controlled nicotine source to replace cigarettes during the quitting process.
  • Relapse prevention: assists individuals who have stopped smoking to maintain abstinence by managing occasional urges.

How It Works

  • Nicotine from Nicorette Bucomist is absorbed through the oral mucosa into the bloodstream, where it binds to nicotinic acetylcholine receptors in the central nervous system. This activation partially mimics the pharmacologic effects of cigarette‑derived nicotine, decreasing the intensity of withdrawal and craving while allowing gradual reduction of nicotine exposure as the user weans off the product. The controlled delivery also stabilizes plasma nicotine levels, reducing the spikes associated with smoking and supporting a smoother transition to abstinence.

Side Effects

Nicorette Bucomist may cause a range of oral and systemic reactions, which are generally categorized by frequency and severity.

Common Side Effects

  • Mouth irritation or soreness
  • Throat irritation
  • Nausea
  • Hiccups
  • Headache

Serious or Rare Side Effects

  • Allergic reaction (rash, swelling, difficulty breathing)
  • Chest pain or palpitations
  • Severe mouth ulceration

Precautions & Warnings

When considering Nicorette Bucomist, several safety measures should be observed to minimize risks.

  • Assess nicotine dependence: evaluate the patient’s smoking history and level of addiction before initiating therapy.
  • Avoid use in recent myocardial infarction: contraindicated in patients who have experienced a heart attack within the past 2 weeks.
  • Do not combine with other nicotine products: concurrent use may increase nicotine exposure and adverse effects.
  • Monitor blood pressure in hypertensive patients: nicotine can transiently raise blood pressure and heart rate.
  • Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Avoid Interactions

Nicotine can influence the activity of several drugs; interactions are classified by clinical significance.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): may potentiate nicotine’s cardiovascular effects.
  • Certain antidepressants (e.g., bupropion): combined use can increase the risk of seizures.

Moderate Interactions (Monitor Closely)

  • Warfarin: nicotine may affect INR; monitor coagulation parameters.
  • Theophylline: nicotine can alter metabolism, requiring level checks.
  • Insulin or oral hypoglycemics: nicotine may affect glucose control; monitor blood sugar.

Frequently Asked Questions

Nicorette Bucomist is an over‑the‑counter nicotine replacement therapy intended to help adult smokers quit. It delivers nicotine through the oral mucosa to reduce cravings and withdrawal symptoms associated with smoking cessation.

The nicotine in Nicorette Bucomist is absorbed across the buccal mucosa into the bloodstream, where it binds to nicotinic acetylcholine receptors in the brain. This partial stimulation mimics the effect of cigarette‑derived nicotine, lowering the intensity of withdrawal and making it easier to taper off tobacco use.

The appropriate dose is determined by the prescribing healthcare professional based on the individual’s smoking history and level of dependence. The prescriber will advise how many units to use per day and the duration of therapy.

Safety data for Nicorette Bucomist in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an enquiry, visit the product page on gnhindia.com, enter the required quantity, and submit the request. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with nicotine patches, Nicorette Bucomist provides rapid, controllable dosing via the oral mucosa, allowing users to adjust intake more flexibly. Unlike inhalers, it does not involve inhalation, which some users find more discreet. Overall, it offers an alternative route of administration that can be combined with other NRT forms under medical guidance.

Store Nicorette Bucomist at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and heat sources to maintain stability and potency.

Place the product between the gum and cheek, allowing it to dissolve slowly. Do not chew or swallow whole; let it release nicotine gradually through the oral mucosa. After the recommended time, remove any residue and avoid eating or drinking for a short period.

Serious adverse reactions, although rare, include allergic responses such as rash, swelling, or difficulty breathing, as well as chest pain, palpitations, and severe mouth ulceration. Users should seek immediate medical attention if any of these symptoms occur.

Nicorette Bucomist should be avoided by individuals who have had a recent myocardial infarction (within the past two weeks), those with uncontrolled hypertension, patients using other nicotine‑containing products, and anyone with known hypersensitivity to nicotine or the product’s excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT